Samira Sakhia - Net Worth and Insider Trading
Samira Sakhia Net Worth
The estimated net worth of Samira Sakhia is at least $1 Million dollars as of 2024-09-18. Samira Sakhia is the Director, Senior Officer of Knight Therapeutics Inc and owns about 186,690 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $1 Million. Details can be seen in Samira Sakhia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samira Sakhia has not made any transactions after 2023-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samira Sakhia
Samira Sakhia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samira Sakhia owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Samira Sakhia’s form 4 insider trades.
Insider Ownership Summary of Samira Sakhia
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2023-05-24 | Director & Senior Officer |
Samira Sakhia Latest Holdings Summary
Samira Sakhia currently owns a total of 1 stock. Samira Sakhia owns 186,690 shares of Knight Therapeutics Inc (TSX:GUD) as of May 24, 2023, with a value of $1 Million.
Latest Holdings of Samira Sakhia
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2023-05-24 | 186,690 | 6.16 | 1,150,010 |
Holding Weightings of Samira Sakhia
Samira Sakhia Form 4 Trading Tracker
According to the SEC Form 4 filings, Samira Sakhia has made a total of 9 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Knight Therapeutics Inc is the acquisition of 20,000 shares on May 24, 2023, which cost Samira Sakhia around $95,000.
Insider Trading History of Samira Sakhia
- 1
Samira Sakhia Trading Performance
GuruFocus tracks the stock performance after each of Samira Sakhia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samira Sakhia is 1.29%. GuruFocus also compares Samira Sakhia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samira Sakhia within 3 months outperforms 5 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Samira Sakhia's insider trading performs compared to the benchmark.
Performance of Samira Sakhia
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.77 | | | | | |
| Relative Return to S&P 500(%) | 0.27 | | | | | |
Samira Sakhia Ownership Network
Samira Sakhia Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Samira Sakhia is the Director & Senior Officer of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Samira Sakhia made 1 insider transaction in Knight Therapeutics Inc (TSX:GUD) with a net purchase of 20,000. Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Samira Sakhia Mailing Address
Above is the net worth, insider trading, and ownership report for Samira Sakhia. Currently GuruFocus does not have mailing address information for Samira Sakhia.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
